Prescribing Pathways to Triple Therapy: A Multi-Country, Retrospective Observational Study of Adult Patients with Chronic Obstructive Pulmonary Disease

INTRODUCTION: Maintenance treatment strategies in COPD recommend inhaled corticosteroid (ICS) + long-acting muscarinic antagonist (LAMA) + long-acting β(2)-agonist (LABA) triple therapy after initial dual therapy. Little is known about how treatment pathways to triple therapy vary across countries i...

Descripción completa

Detalles Bibliográficos
Autores principales: Quint, Jennifer K., O’Leary, Caroline, Venerus, Alessandra, Myland, Melissa, Holmgren, Ulf, Varghese, Precil, Richter, Hartmut, Bizouard, Geoffray, Cabrera, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672143/
https://www.ncbi.nlm.nih.gov/pubmed/33064273
http://dx.doi.org/10.1007/s41030-020-00132-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672143/
https://www.ncbi.nlm.nih.gov/pubmed/33064273
http://dx.doi.org/10.1007/s41030-020-00132-7

Ejemplares similares